Rights and permissions
About this article
Cite this article
Changing from timolol to betaxolol results in increases in both IOP and ocular adverse effects. Inpharma Wkly. 723, 10 (1990). https://doi.org/10.2165/00128413-199007230-00026
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-199007230-00026